President Trump announced that Pfizer agreed to offer lower prices on its drugs to the Medicaid program and directly to patients ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...

Sofi is a doctoral researcher at Virginia Tech specializing in artificial intelligence and health care. In a landmark study from Kenya by Penda Health and OpenAI, an artificial intelligence “safety ...

Torie Bosch is the First Opinion editor at STAT. He joined me on the debut episode of the new season of the “First Opinion Podcast” to discuss how he got started, why more experts should engage on ...

Pauly is a former executive director of the Leonard Davis Institute of Health Economics and Bendheim professor emeritus at Wharton at the University of Pennsylvania. One of the most contentious parts ...

Democrats and Republicans clashed over enhanced ACA subsidies, and failed to reach a deal to fund the government.

The Congressional Budget Office estimates that about 750,000 employees could be furloughed each day during the shutdown at a daily cost of roughly $400 million, though that cost would fall if the ...

The Trump administration’s posture toward the pharma industry has largely been driven by threats, and a tense negotiation over prices. On Tuesday, in the Oval Office, there was talk of friendship.

Pioneering embryologist Shoukhrat Mitalipov reported that his team has encountered hurdles in creating functional human eggs in the lab ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Riding high on the success of its blockbuster weight loss drug, Eli ...